A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
Phase of Trial: Phase III
Latest Information Update: 07 Sep 2018
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Romark Laboratories
- 28 Aug 2018 Planned End Date changed from 1 Oct 2018 to 1 Apr 2019.
- 28 Aug 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Apr 2019.
- 09 Feb 2018 Status changed from not yet recruiting to recruiting.